Skip to main content
. 2024 Jan 24;15(2):501–512. doi: 10.1002/jcsm.13425

Table 1.

Prevalence of sarcopenia according to the consensus definition stratified by CKD stages and KRT.

Meta‐analysis Heterogeneity Inter‐group comparisons
No. of studies No. of patients Prevalence (95% CI) I 2 P value
EWGSOP 0.607
Non‐dialysis 2 153 39.2 (31.5–47.1)
Haemodialysis 15 2919 28.8 (21.9–36.1) 94.2%
Peritoneal dialysis 2 129 10.8 (5.9–16.9)
Dialysis (HD + PD) 3 211 41.4 (21.4–62.9)
Kidney transplant 5 689 26.6 (16.1–38.7) 91.3%
CKD‐grouped 2 285 39.2 (33.6–45.0)
Overall 29 4386 29.7 (24.3–35.4) 93.7%
EWGSOP2 0.238
Non‐dialysis 4 975 8.4 (1.7–19.1) 95.3%
Haemodialysis 12 1144 30.6 (22.3–39.5) 89.3%
Peritoneal dialysis 1 368 11.1 (4.1–27.9)
Dialysis (HD + PD) 1 451 22.2 (18.6–26.2)
Kidney transplant 2 295 10.9 (7.5–14.7)
CKD‐grouped 3 534 13.8 (4.1–27.9)
Overall 23 3767 20.4 (14.9–26.5) 94.6%
FNIH 0.213
Non‐dialysis 2 8840 0.6 (0.5–0.8)
Haemodialysis 1 440 17.0 (13.8–20.8)
Peritoneal dialysis 1 155 15.5 (10.6–22.0)
Kidney transplant 1 120 3.3 (1.3–8.3)
Overall 5 9555 10.6 (1.4–26.5) 98.8%
AWGS 0.276
Non‐dialysis 1 260 25.0 (20.1–30.6)
Haemodialysis 9 7331 21.4 (13.7–30.2) 98.1%
Peritoneal dialysis 3 445 15.9 (4.0–33.4)
Kidney transplant 2 268 13.1 (9.2–17.5)
Overall 15 8304 19.7 (14.1–26.1) 97.2%
AWGS2 0.486
Non‐dialysis 10 2680 17.7 (11.6–24.9) 94.8%
Haemodialysis 26 6356 31.6 (25.6–38.0) 96.3%
Peritoneal dialysis 1 186 38.2 (31.5–45.3)
Kidney transplant 3 300 19.1 (9.0–31.7)
CKD‐grouped 2 656 28.8 (25.3–32.3)
Overall 42 10 178 26.9 (22.7–31.2) 95.6%

CKD, chronic kidney disease; HD, haemodialysis; KRT, kidney replacement therapies; PD, peritoneal dialysis; EWGSOP, European Working Group on Sarcopenia in Older People; AWGS, Asian Working Group for Sarcopenia; FNIH, The Foundation for the National Institutes of Health Biomarkers Consortium Sarcopenia Project.